Other OTC Pharmaceuticals (Pharmacies) - Malawi

  • Malawi
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$5.85m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.46%, resulting in a market volume of US$6.29m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.27 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Malawi is experiencing steady growth and development, driven by various factors such as customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
In Malawi, customers have a strong preference for over-the-counter (OTC) pharmaceutical products due to their accessibility and affordability. OTC products do not require a prescription and can be easily purchased at pharmacies or drugstores. This convenience factor is highly valued by customers, especially in rural areas where access to healthcare facilities may be limited. Additionally, OTC products are often priced lower than prescription medications, making them more affordable for the majority of the population.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals market in Malawi is the increasing demand for herbal and traditional medicines. Malawi has a rich tradition of using herbal remedies for various ailments, and this trend has continued to gain popularity in recent years. Customers are turning to herbal medicines for their perceived natural and holistic benefits, as well as their affordability. This has led to a rise in the availability and variety of herbal OTC products in pharmacies across the country. Another trend in the market is the growing focus on preventive healthcare. Customers are becoming more proactive in managing their health and are seeking OTC products that can help prevent common illnesses and promote overall well-being. This has led to an increased demand for vitamins, dietary supplements, and other preventive healthcare products. Pharmacies in Malawi are responding to this trend by expanding their range of OTC offerings and providing customers with a wider selection of preventive healthcare products.

Local special circumstances:
Malawi is a landlocked country in southeastern Africa with a predominantly rural population. This poses unique challenges in terms of healthcare access and distribution of pharmaceutical products. Pharmacies play a crucial role in bridging this gap by providing essential healthcare services and OTC products to communities across the country. The government has also implemented various initiatives to improve the availability and affordability of OTC pharmaceuticals, such as the establishment of community pharmacies in underserved areas.

Underlying macroeconomic factors:
The growth of the Other OTC Pharmaceuticals market in Malawi is also influenced by underlying macroeconomic factors. The country has been experiencing steady economic growth in recent years, which has contributed to an increase in disposable income and consumer spending. This has had a positive impact on the OTC pharmaceutical market, as customers have more financial means to purchase healthcare products. Additionally, the government's efforts to improve healthcare infrastructure and services have created a favorable environment for the growth of the OTC market. In conclusion, the Other OTC Pharmaceuticals market in Malawi is developing and growing due to customer preferences for accessible and affordable healthcare products, trends such as the demand for herbal medicines and preventive healthcare, local special circumstances that necessitate the role of pharmacies in healthcare delivery, and underlying macroeconomic factors that support consumer spending on OTC pharmaceuticals.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)